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We utilized the simian immunodeficiency virus model of AIDS to examine evolution of nef gene in gut-associated lymphoid tissue
(GALT) during primary and early asymptomatic stages of infection. Macaques were infected with a cloned virus, SIVmac239/nef-stop
harboring a premature stop codon in the nef gene. Restoration of the nef open reading frame occurred in GALT early at 3 days post-infection.
Analysis of nef sequences by phylogenetic tools showed that evolution of nef was neutral thereafter, as evidenced by the ratio of synonymous
to nonsynonymous substitutions, a star pattern in unrooted trees and distribution of amino acid replacements fitting a simple Poisson process.
Two regions encoding for a nuclear localization signal and a CTL epitope were conserved. Thus, GALT was a site for strong positive
selection of functional nef during initial stages of infection. However, evolution of the nef gene thereafter was neutral during early
asymptomatic stage of infection.
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Human immunodeficiency virus (HIV) and simian
immunodeficiency virus (SIV) infections are characterized
by a high degree of viral genomic diversity which could
arise from a combination of transcription errors by the error-
prone reverse transcription and immune-mediated positive
selection for viral variants (Bebenek et al., 1989; Bon-
hoeffer et al., 1995; Coffin, 1996; McMichael and Phillips,
1997; Roberts et al., 1988; Temin, 1993). HIV appears to
evolve differentially in various tissues including lymph
nodes, brain and lung (Ait-Khaled et al., 1995; Delassus
et al., 1992; Haggerty and Stevenson, 1991; Itescu et al.,
1994; Kodama et al., 1993; Korber et al., 1994; Wong et al.,
1997). Molecular evolutionary studies have examined the
role of viral evolution in disease progression by performing
longitudinal analysis of genetic diversity and divergence
in vivo (Ganeshan et al., 1997; Shankarappa et al., 1999;0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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showed a positive relationship between the genetic diver-
sity and disease progression. However, others have reported
a lack of relationship between emergence of viral variants
and disease outcomes (Markham et al., 1998; Ross and
Rodrigo, 2002; Strunnikova et al., 1995, 1998; Zanotto
et al., 1999).
Gut associated lymphoid tissue (GALT) harbors more
than 80% of the total lymphoid tissue in the body. It is an
early site for active HIV and SIV replication, and severe
depletion of CD4+ T cells accompanied by CD8 T cell
lymphocytosis and virus specific cytotoxic T cell (CTL)
responses (Heise et al., 1993; Mattapallil et al., 1999;
Shacklett et al., 2000; Smit-McBride et al., 1998; Veazey et
al., 1998). Since GALT provides a microenvironment
conducive for active viral replication, it may serve as an
ideal site for viral evolution and a source for the emergence
of viral variants that could be attributed to the disease
outcome (Deacon et al., 1995; Kestler et al., 1991; Kirchh-
off et al., 1995; Kodama et al., 1993; Mariani et al., 1996).
Data on the evolution of viral variants in GALT during
primary SIV or HIV infection are either limited or005) 1 – 11
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viral replication coincides with severe CD4+ T cell depletion
in the GALT and this is followed by a clinically asympto-
matic stage with decreased viral loads. Both CD4+ T cells
and macrophages are important targets of HIVand SIV in the
GALT. However, due to changes in mucosal cell populations
following severe loss of CD4+ T cells, macrophages may
serve as an important viral reservoir. It is unclear whether
divergence of viral variants would reflect the changes in
GALT microenvironment and consequently disease stages.
The nef gene of HIV and SIV encodes for a 25–27 kDa
multifunctional protein that has been shown to play a key
role in SIV and HIV pathogenesis (Piguet and Trono, 1999;
Trono, 1995). While Nef is not required for viral replication
in tissue culture, it is necessary for the development of high
viral loads and disease progression in vivo (Kestler et al.,
1991). Experimental infection of adult rhesus macaques
with SIVmac239 virus with nef deletions showed low viral
loads, near normal CD4+ T cell counts and absence of
disease symptoms (Deacon et al., 1995). The importance of
nef gene in HIV-1 infection is suggested by the findings that
a few HIV-1-infected long-term nonprogressors with low
viral loads harbor HIV variants containing deletions in the
nef gene (Deacon et al., 1995; Kirchhoff et al., 1995). These
studies and others suggested that mutations in the nef gene
could impact disease outcome in SIV and HIV infections
(Huang et al., 1995; Shugars et al., 1993). In contrast, some
studies did not find any correlation between nef gene
variation and disease progression (Mourich et al., 1999; Zhu
et al., 1996).
Evolutionary theories have been used to gain insights
into the correlation between viral population dynamics,
host–pathogen interactions, disease progression and clinical
outcome (Domingo et al., 1996; Nowak et al., 1991;
Tersmette et al., 1989; Williamson, 2003; Wolinsky et al.,
1996). An application of evolutionary theories will be
valuable to interpret viral sequences derived from the GALT
of SIV-infected macaques or HIV-infected patients with
diverse disease progression rate. Two models can be
considered in the study of evolution of nef variants. The
adaptive model postulates that new quasi-species in the viral
population may have a selective advantage over the
ancestral strain or possibly may survive better in the later
stages of infection. Under the adaptive model, selective
forces include host immune responses, replication fitness,
cell tropism and co-receptor usage which may greatly
influence viral genetic variation. Positive selection results
in the distribution of genetic variants about the best-adapted
genotype. The frequency of these variants in the quasi-
species reflects the competitive advantage of some variants
to replicate over others. Positive selection ensures efficient
outgrowth of variants with enhanced replication fitness
while negative selection eliminates low fitness mutants. On
the other hand, the neutral model postulates that emergence
of new variants is based on random events and these
variants have no selective advantage. As a result, variants inthe viral quasi-species may not show preferentially mutated
codons.
In the present study, we tested the hypothesis that the
selection and emergence of nef variants occur in the GALT
during the early stages of infection and that these dominant
variants may partly account for the variable disease
outcomes observed in HIV-1-infected patients and SIV-
infected macaques. To study the evolution of the nef gene in
the GALT, 11 rhesus macaques were inoculated with
SIVmac239/nef-stop virus and examined for genetic diver-
sity of the nef gene at 3 days to 23 weeks post-infection
(wk pi), a time period spanning the development of primary
SIV infection and early asymptomatic period following the
resolution of primary acute stage of infection. SIVmac239/
nef-stop virus is a molecular clone that results in a single
viral species with a single nef gene sequence variant in the
early stages of infection. This molecular clone has a TAA
premature stop codon at position 93 of Nef that abrogated
the synthesis of a full-length functional Nef in vivo (Kestler
et al., 1990). Evolution of the nef gene in vivo involved the
reversion of this stop codon to synthesize a full-length
functional Nef protein. The use of this molecular clone has
allowed us to examine the viral genetic diversity during the
course of infection in the absence of confounding factors
such as the complexity of infecting quasi-species, selection
of variants at the time of viral transmission and the biologic
phenotype of the infecting virus. We sought to examine the
correlation between genetic variations in the nef gene in
GALT during primary SIV infection in the context of viral
loads and disease progression. Our results demonstrated that
GALT is an early site for positive selection of full-length
functional Nef with a reversion of the stop codon to an open
reading frame immediately following infection. However,
thereafter, the evolution of the nef gene was neutral as
confirmed by the comparison of synonymous and non-
synonymous substitution rate and monophylogenetic star
topology that supports the neutral model of evolution.Results
Viral burden in GALT during primary and asymptomatic
stages of SIV infection
The presence of SIV infection was detected in jejunal
tissue samples of 11 rhesus macaques at different time
points following SIVmac239/nef-stop infection (3 days to
23 wk pi). This time period spanned the development of
primary acute stages of infection with high viral loads and
subsequent asymptomatic period with suppressed viral loads
in response to the host anti-viral immune responses. The
viral RNA levels were quantified by bDNA assay (Table 1)
and virally infected cells were localized by in situ hybrid-
ization (data not shown). The peak viral loads were detected
at 2 wk pi (1  107 RNA copies/mg of tissue). However,
one of the four animals at 2 wk pi had relatively lower SIV
Table 1
Animal numbers, necropsy time points, viral load and percentage of stop
codon reversions
Animal # Necropsy time point
(weeks post-infection)
Viral load log10
RNA copies/ml
of plasmaa
% stop codon
revertantsb
25541 3 daysc 3.95 77
25546 1 3.95 11
25605 2 7.06 71
25618 2 6.55 64
23894 2 3.00 90
23930 2 7.32 45
24231 8 5.3 100
24255 8 4.22 91
24219 13 4.11 93
24242 23 5.67 100
24263 23 3.90 66
a Plasma viral loads were determined by bDNA assay.
b Percentage of revertants represents the % of clones that were found to
have reversed the early stop codon at position 93 of the parental inoculum.
c Reversion of stop codon to generate a full-length Nef occurred early in
infection (3 days) as seen in rhesus macaque 25541.
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loads declined (1  104 and 1  105 RNA copies/mg tissue)
by 2 to 3 logs in animals during the asymptomatic stage of
infection (8 to 23 wk pi). One of the two animals at 8 wk pi
did not have detectable levels of anti-SIV antibodies and
was considered to be a rapid progressor. This particular
macaque had a high viral load (1  106 RNA copies/mg
tissue). There was a 1.5 log difference in viral loads between
the rapid progressor and animal with a regular disease
course at 8 wk pi. At 23 wk pi, one of two rhesus macaques
displayed high viral loads. The variation in jejunal tissue
viral loads between the two macaques at 23 wk pi may be
explained by the presence of viral targets and reservoirs that
sustain viral replication in the macaque with high viral
loads.
Early selection of a full-length Nef reading frame in GALT
by reversion of premature stop codon in
SIVmac239/nef-stop virus
We examined the status of the premature stop codon at
position 93 of the Nef protein among the deduced amino
acid sequences from intestinal tissues at different time
points following SIV239/nef-stop infection. In 10 of 11
animals in the study, a majority of the nef variants had
reversions of the premature stop codon (TAA) to CAA (Q),
GAA (E) or in-frame deletion of the entire stop codon. At
day 3 post-infection, all 10 nef variants derived from GALT
of rhesus macaque 25541 had a reversion of the premature
stop to a sense codon (Table 1, see Supplementary Figs. A
and B). In the remaining 10 of 11 animals, the majority of
the clones showed a reversion of the premature stop codon
to either a glutamine or glutamic acid residue with an
exception of animal 24255 analyzed at 8 wk pi with a rapid
disease course. In three of the 10 nef variants derived fromthis animal, the premature stop codon was substituted with a
tyrosine residue. In rhesus macaque 25546 sacrificed at 1
wk pi, six of seven clones retained the premature stop codon
suggesting that reversion of the stop codon occurred in vivo
(Fig. A1). This strongly supports for an essential role of a
functional Nef protein during the early stages of infection in
lymphoid tissue as well as its importance in disease
progression and development of high viral loads as pre-
viously reported (Kirchhoff et al., 1999).
Phylogenetic analyses of nef sequences
To construct evolutionary relationships of the SIV nef
gene sequences among all 11 SIV-infected rhesus macaques
during the course of SIV infection with different viral loads,
phylogenetic analyses were performed using the PHYLIP
program package (Felsenstein, 1989). Pairwise comparisons
and distance matrices were generated using Dnadist
program (Distance matrix program). Phylogenetic trees
were constructed from the distance matrices using the
Neighbor TreeMaker Program. Final tree topologies were
visualized with TreeView.
We have used unrooted trees to display this information.
The radial tree topologies consistently showed that the
sequences from each animal clustered together and
resembled a star burst topology with branches radiating
from a point of divergence. In most cases, the center of the
star was one step from the parental SIVmac239 nef-stop
variant as shown by the phylogenetic trees of nef gene
sequences from three of 11 macaques (Figs. 1A–C). We
have interpreted this star pattern to mean that, beyond the
reversion of the premature stop codon, other amino acid
replacements are neutral. Expectations of the adaptive
model would show an emergence of an adaptive variant
out of one of the branches upon which new variants would
emerge (i.e. appearance of a star out on the branch). Within
the phylogenetic trees, all sequences radiated from the
putative parental node (SIVmac239/nef-stop) indicating
increasing divergence with time but with no evidence that
any of the variants were favored over ancestral forms, other
than the selective pressure for the stop codon (position 93)
to change in order to produce an open reading frame. These
results emphasize the importance of the functional nef gene
expression in lymphoid tissue during the early stages of
viral infection.
To further investigate the phylogenetic relationship
between sequences from different animals in primary and
asymptomatic stages of SIV infection, phylogenetic analy-
ses were performed on variants pooled from all 11 animals
(Fig. 2). As was seen in Fig. 1, no unique clustering of
variants derived from either early or asymptomatic stages of
infection was observed. Likewise, there were no clustering
similarities between rapid and slow disease progressors.
These data show that different variants evolved in different
animals independent of the phenotype or lineage of cellular
reservoirs, disease stage or outcome.
Fig. 1. Phylogenetic analysis of nef sequences from rhesus macaques at different stages of SIV infection. Unrooted phylogenetic tree of variants from rhesus
macaques (A) 24219; (B) 24231; (C) 25605. Nef sequences where used to construct a neighbor-joining consensus tree as described in Materials and methods.
The scale bar represents 0.01 substitutions per nucleotide position (s/nt). Sequence identities are coded as follows: the first two digits refer to the disease stage
post-infection; the third, four and fifth digits stand for the last three digits of the animal number, while the last two digits stand for the clone number. Thus,
sequence ‘‘0823109’’ can be decoded as ‘‘08’’ week post-infection; rhesus macaque number (24231) and clone # 09.
Fig. 2. Unrooted tree of SIV nef sequences from all 11 SIV-infected rhesus macaques. The trees show a distribution of a group of 60 sequences pooled from the
11 SIV-infected rhesus macaques shown in Table 1. Other tress reconstructed from sequence data sets from individual animals display a similar star phylogeny.
Sequence identities are coded as describe in the Fig. 1 legend. Half of the sequence numbers have been omitted from the figure for presentation purposes.
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neutral evolution
Nef variants have been suspected to vary with disease
progression. This has led to the speculation that particular
variants may be associated with different stages of disease,
cellular targets and reservoirs or clinical outcome (Shpaer
and Mullins, 1993; Zanotto et al., 1999; Zhu et al., 1996).
The phylogenetic pattern of amino acid substitutions
observed in the different animals (as shown in Figs. 1 and
2) appeared unrelated to disease outcome and hence the
occurrence of these substitution may be random. A common
analytical approach to address whether or not amino acid
replacements are selected over parental genotypes is to
compute the rate of synonymous (silent or ds) and
nonsynonymous (amino acid altering or dn) nucleotide
substitutions. The ratio of synonymous to nonsynonymous,
ds/dn, is indicative of whether base substitution at a
degenerate site is positively selected, negatively selected
or neutral (Nei and Gojobori, 1986). The idea behind this
approach is that if mutations were selected, we would expect
dn to have a higher value than the one that would be
expected from simple mutation pressure (which is the factor
that determines the value of ds). Thus, the ds/dn ratio
(where ds is the number of silent or synonymous mutations
per synonymous site and dn is the number of amino acid
replacements per nonsynonymous site) can be regarded to
reflect the relative rate of nef evolution and the selection for
or against amino acid changes. The values for the ds/dn of
the nef gene in 11 rhesus macaques are shown in Table 2.
The ratios varied from 0.73 to 3.65 with a mean ratio of
1.84. If all codon positions observed were equally free toTable 2
Synonymous and nonsynonymous substitutions
Animal # Sd Sn ds/dn
25541 6 19 2.15
25546 2 7 2.46
25605 4 14 1.97
25618 15 16 1.77
23894 7 9 1.74
23930 4 11 1.23
23231 10 48 1.29
24255 7 14 2.88
24219 6 12 3.65
24242 6 19 .73
24263 1 18 1.43
Weighted average 1.84
ds and dn are substitution rates in terms of the observed number of
synonymous and nonsynonymous changes divided by the total number of
synonymous and nonsynonymous changes possible. The numbers are
computed from the comparison of SIVmac239 Nef stop sequence to each of
the other sequence variants from the same animal. ds/dn is a weighted
average from those comparisons. Sd is the total number of observed
synonymous changes and Sn is the total number of observed nonsynon-
ymous changes within each sequence data set. The variance of ds/dn values
among the different animals is expected for a stochastic process acting under
a mean of 1.84.vary without selection either for or against mutations in nef,
then a ratio greater than 1.0 would be expected. If transition
and transversion mutations were equally likely, the ratio
would be expected to be exactly 1.0; however, since tran-
sition rates are greater than transversion and third position
transitions favor synonymous changes, the ratio of ds/dn
would be expected to be >1.0. A value of 1.84 is just
slightly greater than would be expected, so we reasoned
that the relatively moderate ds/dn ratio is suggestive of nef
being under extremely weak functional constraint against
amino acid replacements. If there was a positive selection
for amino acid replacements, a ds/dn <1 would be
expected; hence, we saw no evidence for positive selection.
Based on the comparison of ds/dn (Table 2) with viral
load and infection course (Table 1), no obvious difference in
ds/dn ratios could be discerned between animals at different
stages of infection or with divergent disease outcome.
Indeed, the differences observed in the ds/dn ratios in Table
2 are not statistically significant. So far, our phylogenetic
analysis is consistent with the null hypothesis that all of the
amino acid changes observed in nef are neutral. Perhaps
more surprisingly, there is only the smallest indication of any
functional constraint acting on nef with the exception of
maintaining an open reading frame. As we show below, there
are two short regions that seem to display functional
constraint and are highly conserved.
Linear distribution of amino acid replacements in Nef are
Poisson distributed or nearly indistinguishable from
random
If amino acid replacements in Nef protein were completely
neutral, we would expect to see these changes across the
protein to be randomly distributed or to state this in statistical
terms, to be Poisson distributed. The probability that any
region of length (d) across the gene has zero mutations would
be given by the zero term of the Poisson distribution, emd,
wherem is themutation frequency (Syvanen, 1984). This will
give the probability that the codons are contained within a run
(defined as a cluster of adjacent amino acids with zero
replacements or no changes) that is greater than or equal to d.
Thus, the probability of having a run between i and j codons
in length is:
emi  emj:
This term multiplied by the total number of mutations +1
will give the expected number of runs of that size within the
gene under study. A correction for multiple hits that produce
only a single (or zero) observed change is not needed in the
current study because the total number of mutations is
relatively low.
The actual distribution of amino acid changes observed in
this study and a display of each codon position and
the numbers of replacements encountered are shown in
Fig. 3. This distribution of amino acid changes can be com-
pared with the expectation of a purely random process. A
Fig. 3. Linear distribution of deduced amino acid replacements across the SIVmac239 Nef protein. The number of substitutions per amino acid position is
indicated on the y axis while the amino acid position is shown on the x axis. Observed deletions 1, 2, 3 and 4 are indicated by thick bold lines while gap regions
A and B are shown with a thin line below the amino acid positions. Known functional domains e.g. nuclear localization signal, PxxP and RR motifs are
indicated with thick bold dotted lines. The distribution of amino acid replacements was compiled from all of the variants encountered in the study from all 11
rhesus macaques.
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positions. If each position was as free to vary as any other,
we would conclude that the probability for any codon to
experience a change is 233/263, which is the mutation
frequency for this study. We have calculated the expected
distribution from this number using the equation derived
in the previous paragraph. The results of the observed
and expected number of amino acid replacements per codon
position are shown in Table 3. It is evident that there is no
significant difference between the observed and expected
distributions (the chi square value is 3.5 over 5 degrees of
freedom). Thus, overall replacements in Nef protein are
Poisson distributed or indistinguishable from random.
There is one feature of the linear distribution amino acid
substitutions depicted in Fig. 3 that does appear to vary from
the expectations of a purely random process. This is the
presence of a cluster of adjacent amino acids with zero
replacements that can be called runs of zero hits. There are
two regions that seem to have fewer mutations than expected.
One region consists of a 15 amino acid cluster from positionTable 3
Number of adjacent codons with zero mutations
Na Observedb Expectedc
0 114 108
1 86 97
2 48 43
3 12 12.8
4 4 3
5 1 0.5
a Size of run of codons with zero mutations.
b Number of runs of size N that are encountered at each codon and
derived from F).
c Expected number of runs from a Poisson process (see text). Where m =
233/263.11 to 25 and the other run is made of an 11 amino acid cluster
from position 135 to 145. These two runs could represent
domains of Nef that are functionally constrained. The first
run, residues 11 to 25, encompasses a region postulated to
be a putative nuclear localization signal. The second run
(residues 135 to 145) includes the di-arginine motif (137–
138) and a CTL epitope (Mortara et al., 1998, 2000; Sawai
et al., 1996). Based on our data, we conclude that the nef
gene has two noncontiguous regions that appear to be
functionally constrained on the basis of amino acid
replacement rates. The remaining regions of Nef are free
to vary randomly.
Amino acid substitutions in Nef functional domains
Our analysis shows that the overall pattern of changes
can be accounted for by neutral evolution theory. However,
this is not to say that some of the changes did not
influence disease outcome. We identified specific amino
acid substitutions in known functional domains of SIV Nef
protein or at regions proximal to these domains. These
amino acid substitutions occurred randomly and at very
low frequencies in any particular animals. No commonly
shared substitutions were observed among the asympto-
matic animals except for random, low frequency, nonun-
ique amino acid changes. A Q41K substitution was
observed in five of nine clones in macaque 23242 at 23
wk pi. This substitution lies within the SQS motif involved
in AP-1 recruitment and endocytosis. We also observed a
V102M substitution in six of the nine clones at the PxxP
domain in the same animal (Supplementary Fig. B). This
proline rich motif is involved in SH3 binding and MHC-1
down-regulation. No relationship was established between
specific amino acid substitution at functional domains of
Nef protein and disease stage.
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SIV-infected animal with a rapid disease course
To investigate whether any specific mutations in Nef
were associated with a rapid disease course, we analyzed
SIV-Nef variants from two rhesus macaques 24231 and
24255 which showed diverse infection course (regular vs.
rapid) at 8 wk pi. With regard to the occurrence of unique
and animal specific substitutions, an E188G substitution
was observed in four of 10 clones derived from an animal
24231 with a regular disease course (Supplementary Fig. B).
This site has been shown to be important for COP-1
recruitment, that is involved in Nef-induced CD4 down-
regulation (Janvier et al., 2001). Whereas, a unique
reversion of the premature stop at position 93 to tyrosine
(Q93Y) was observed in three of the 10 clones derived from
the rapid progressor animal (24255). This substitution falls
within the central acidic cluster shown to be involved in
MHC-1 down-regulation (Schwartz et al., 1996). Thus, the
main difference observed between these two animals was
the substitution of premature stop with a tyrosine residue at
position 93 observed in the rapid progressor (24255), and
the presence of E188G in variants derived from rhesus
macaque with a regular disease course.
Analysis of amino acid substitutions at Nef CTL epitopes
HIV-1-specific CTL responses are an important compo-
nent of host immune responses in suppressing HIV-1
infection. Knowledge of CTL epitopes is critical for the
development of effective HIV vaccines. We examined the
occurrence of amino acid substitutions at SIV Nef CTL
epitopes listed in the Los Alamos HIV molecular Immunol-
ogy database. In addition, Nef CTL epitope (128–137) and
(159–167) regions were previously reported to be sites for
the emergence of CTL escape variants in SIV-infected
rhesus macaques immunized with Nef peptides. We defined
Nef CTL escape variants as those clones in which 50% or
more of the clones harbored amino acid substitution at
the CTL epitopes. Interestingly, the CTL epitope region
(159–167) displayed a Y167F variability at position 167 in
six of nine clones derived from rhesus macaque 24242 with
high viral load at 23 wk pi. All the other CTL epitopes
including epitope cluster 128–137 were highly conserved.
Our results show a Y167F substitution at Nef CTL epitope
cluster (159–167) in one of 11 animals. However, whether
this substitution facilitates immune evasion was not
determined in our study.Discussion
The genetic variability in HIV and SIV is due to high
mutation rates generated during reverse transcription by the
error-prone viral encoded reverse transcriptase (Goodenow
et al., 1989; Hahn et al., 1986; Meyerhans et al., 1989;Zhang et al., 1997). One of the major questions is how
selective pressure exerted by the host immune system or
other pathogenic factors contribute to these complex
mixture of genetically diverse but related viral quasi-species
(Kimata et al., 1999; McNearney et al., 1992; Pang et al.,
1992; Zhu et al., 1993). Besides intrinsic host factors, viral
genetic diversity has been shown to contribute to the
variable disease outcome observed in HIV-1-infected
patients and macaques experimentally infected with SIV.
Nef, an auxiliary gene of HIV and SIV, is not required for
viral replication in cell culture, but is an important viral
determinant for the development of high levels of viremia
and disease progression in vivo (Deacon et al., 1995; Kestler
et al., 1991; Sawai et al., 2000). This is further supported by
the observation that infection of rhesus macaques with
molecularly cloned SIV bearing defined mutations at
various domains of Nef shows variations in disease course
suggesting that Nef variants may impact on disease course
and outcome in SIV and HIV infection (Hahn et al., 2003;
Kestler et al., 1991; Kirchhoff et al., 1999; Mortara et al.,
1998; Mortara et al., 2000; Sawai et al., 2000; Stephens
et al., 1996).
Our study on the evolution of the nef gene sequences in
GALT of rhesus macaques at 3 days to 23 wk pi
demonstrated that there is a strong selective pressure for
restoring the nef open reading frame in vivo in GALT
immediately following infection. All but one animal (at 1
wk pi) restored the nef open reading frame. However,
beyond this change, all subsequent changes appear to be
completely random. Neutrality of nef evolution is supported
from an analysis of variants in nef using three different
molecular evolutionary procedures. First, the star phyloge-
nies in Figs. 1A–C and Fig. 2 provide evidence that is
consistent with a model that the evolution of the nef gene is
neutral during the early stages of infection.
Second, the ratio of substitutions in nef that cause amino
acid replacements to those that are silent (the ds/dn ratio) is
very close to the value expected for random variations of the
genetic code when translational stop mutations are lethal
(Table 2). This means that the rate of amino acid replace-
ments is very close or slightly less than the rate expected
from the mutation rate itself. Thirdly, the distributions of
changes across the gene are predictable by a Poisson
process. Even though casual examination of the distribution
of variants (Fig. 3) appears to reveal hyper-variable regions,
these are expected by chance (Table 3).
However, one deviation from a purely random process of
amino acid replacements is seen in two regions that contain
a run of nonmutated amino acids that are adjacent to
one another. These regions include residues 11 to 25 at the
N-terminus nuclear localization signal. The second region
(residues 135 to 145) encompasses a CTL epitope and the
RR (137–138) motif shown to interact with cellular serine
kinases and implicated in pathogenesis. Previous studies
have reported the emergence of CTL escape variants in SIV-
infected rhesus macaques immunized with SIV Nef peptides
T. Ndolo et al. / Virology 343 (2005) 1–118containing Nef CTL epitopes (Nef 125–147 and 128–137)
prior to the challenge with pathogenic SIV (Evans et al.,
1999; Friedrich et al., 2004). These studies suggested that
immune responses against Nef CTL epitopes might have
exerted selection pressures facilitating the adaptive evolu-
tion and emergence of Nef variants within Nef CTL epitope
regions (O’Connor et al., 2002; Peyerl et al., 2004). In our
study (experimental SIV infection in absence of prior
immunizations), the second run (defined as a cluster of
adjacent amino acids with zero replacements) of amino acid
residues harboring a Nef CTL epitope with zero substitution
rates indicated that the evolution of this particular Nef CTL
epitope region was constrained. In support of our findings,
the evolutionary constrained region of Nef observed in our
study, residues 135–145 correspond to the highly hydro-
phobic crevices between the two anti-parallel alpha helices
in the highly conserved core of Nef protein (Bauer et al.,
1997; da Silva and Hughes, 1999; Peyerl et al., 2004; Zhang
et al., 1997). It has been suggested that Nef CTL epitopes
tend to coincide with structural and functional domains and
thus not free to vary randomly (Hahn et al., 2003; Padua et
al., 2003; Plikat et al., 1997; Yang et al., 2003; Zhu et al.,
1996). This would be consistent with the lower rates of
evolution at these regions.
Previous studies have attempted to delineate the evolu-
tionary properties of nef in viral replication and patho-
genesis (Plikat et al., 1997). Plikat et al. monitored HIV-1
nef quasi-species that appeared in a single patient infected
with HIV following blood transfusion and showed that
short-term evolution of HIV-1 nef quasi-species was
consistent with the neutral model. More recently, evaluation
of the evolutionary dynamics and conservation of functional
domains of HIV-1 Nef during maternal–fetal transmission
indicated that both maternal and infant nef sequences were
under positive selection pressure and that amino acid
substitutions at most of the sites including functional
domains essential for Nef activity were either conserved
or neutral (Hahn et al., 2003). Our study, for the first time
has examined nef sequences in GALT during primary and
early asymptomatic stages of viral infection. Our results are
consistent with Plikat et al. (1997) study but do not support
the work of Hahn et al. (2003).
In summary, GALT is an early site for strong positive
selection for functional full-length Nef during primary SIV
infection. This was evidenced by the reversion of the
premature stop codon in SIVmac239/nef stop. Using
molecular evolutionary tools, we show that SIVmac239
nef variants in GALT emerge by neutral evolution. Through
the nef sequence analysis, we have identified for the first
time, two functionally constrained regions in Nef, a
putative nuclear localization signal and a previously
characterized CTL epitope that are highly conserved and
may be important for nef function. Detection of conserved
regions of Nef through phylogenetic analyses may identify
potential targets for development of HIV vaccines and new
therapeutics.Materials and methods
Animals, virus infection and tissue collection
Eleven rhesus macaques (Macaca mulata) from the
California Regional Primate Research Center (CRPRC)
were used in this study. Animals were sero-negative for
simian T cell leukemia virus-1 (STLV-1) and simian
retrovirus-1 (SRV-1). All animals were housed in accord-
ance with American Association for Accreditation of
Laboratory Animal care guidelines. Rhesus macaques were
intravenously inoculated with SIVmac239/nef stop, a
molecularly cloned virus. This clone has a premature TAA
stop signal at codon 93 of the nef gene (Kestler et al., 1990,
1991). Animals were euthanized during primary infection
and in clinically asymptomatic infection. Animals in
primary SIV infection were sequentially sacrificed at 3 days
post-infection (pi) (n = 1), 1 wk pi (n = 1) and 2 wk pi (n =
4). Whereas, animals in asymptomatic stage of infection
were euthanized at 8 wk pi (n = 2), 13 wk pi (n = 1) and 23
wk pi (n = 2) (Table. 1). Intestinal tissues were collected at
necropsy and immediately frozen in liquid nitrogen for the
determination of viral loads and for the isolation of genomic
DNA.
Quantitation of SIV RNA loads
SIV RNA loads in intestinal tissue samples were
determined by branched DNA (bDNA) assay (Bayer
Diagnostics, Emeryville, CA) as previously described
(Pachl et al., 1995).
DNA isolation and amplification of SIV nef gene
Genomic DNA was extracted from frozen jejunal tissues
obtained at necropsy by proteinase K treatment, phenol/
chloroform purification and ethanol precipitation. SIV nef
sequences were amplified by nested PCR using outer
primers [sense, 5V-CAGGACTGAACTGACCTACCTACA-
ATATGG-3V (nt 9051–9080); antisense, 5V-ACATCCCCTT-
GTGGAAAGTCCCTGCTGTTT-3V (nt 9868–9898)] and
inner nef specific primers [sense 5V-TGGGTGGAGCTATT-
TCCATGAGGCGGTCC-3V (nt 9077–9106); antisense 5V-
TCAGCGAGTTTCCTTCTTGTCAAGCCAT-3V (nt 9842–
9868)], numbering based on SIVmac239 genome (Gene
accession no. M33262) (Regier and Desrosiers, 1990).
The PCR reactions were performed in 1 PCR reaction
buffer containing1.5 mM MgCl2, 200 AM each of the four
dNTPs (dATP, dCTP, dGTP and dTTP), 1.5 pmol of each
primer pair, 1 Ag of template DNA and 2.5 U of Expand
High Fidelity Polymerase (Boehringer Mannheim). The
thermal cycling conditions for the first round PCR
amplification were as follows: first, the template DNA was
denatured at 93 -C for 3 min, followed by 35 cycles using
the following profile: denaturation at 93 -C for 1 min,
annealing at 55 -C for 1 min and extension at 72 -C for 3
T. Ndolo et al. / Virology 343 (2005) 1–11 9min. For the nested PCR amplification, 1 Al of first round
product was used and the same thermal cycling conditions
were applied except for an additional extension at 72 -C for
20 min.
Cloning and sequencing of nef variants
PCR products from three different PCR reactions per
animal sample were pooled together and cloned into TOPO
TA cloning vector (Invitrogen Corp., San Diego, CA).
Ligated DNA was transfected into competent DH5a cells.
Ten clones or more per animal were randomly selected and
plasmid DNA purified using Qiagen Miniprep Kit (Qiagen).
Clones were sequenced bi-directionally using a Taq Dye-
Deoxy Terminator cycle sequencing kit (Amersham Life
Sciences, Piscataway, NJ). Sequence editing was performed
using Sequencher 3.0 software (Gene Codes, Ann Arbor,
MI). Nucleic acid and deduced amino acid sequence align-
ments were performed with Vector NTI Suite software
(InforMax Inc., Frederick, MD) and Clustal X (Thompson
et al., 1997).
Phylogenetic sequence analyses
Multiple nef gene sequence alignments were performed
using Clustal X program (Thompson et al., 1997). Final
alignments were manually edited to eliminate gaps.
Phylogenetic analyses were performed using the neigh-
bor-joining method available in the PHYLIP program
package (Phylogeny Inference Package, written by J Fel-
senstein) (Felsenstein, 1989). Dnadist program (Distance
matrix program) was used to perform pairwise nucleotide
comparisons and generation of distances matrices. Phylo-
genetic trees were constructed from the distance matrices
by the neighbor-joining method using the Neighbor Tree-
Maker Program. Final tree topologies were visualized with
TreeView.
Synonymous Nonsynonymous Analysis program (SNAP)
written by B Korber (http://hiv.lanal.gov) was used to
estimate rate of synonymous (ds) and nonsynonymous (dn)
substitutions as computed by method of Nei and Gojobori
(Korber, 2000; Nei and Gojobori, 1986). This method defines
ds as the number of observed synonymous substitutions per
possible synonymous substitution and dn as the number of
observed nonsynonymous substitutions per possible non-
synonymous substitutions.Acknowledgments
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